Drug Delivery Markets, Vol I: Oral Delivery
Chapter one: Executive Summary
- Market Drivers
- Market Size and Growth
- Total Oral Drug Delivery Market
- Oral Drug Delivery Technology Only Market
- Competitive and Market Analysis
Chapter two: Introduction and Overview
- Scope of the Report
- Methodology
- History of Oral Drug Delivery
- Phases of Drug Action
- Barriers to Oral Drug Delivery
- Controlled-Release/Sustained-Release
- Delayed Release and Modified Release
- Fast Dissolving
- Taste-Masked
- Pulsatile Release
- Microemulsion and Others
Chapter three: Key Trends and Demographics
- The Elderly
- Regulatory Environment
- Patent Protection and Extension
- Earlier Involvement
- Consolidation
- Proprietary Product Development
- Implications for Generic and Over-the-Counter Products
- Pharmaceutical Formulation
Chapter four: New Developments
- Macromolecule Delivery
- Delivery of Hydrophobic Drugs
- Other Delivery Solutions
Chapter five: Market Size and Growth
- The Total Oral Drug Delivery Market
- Oral Delivery Technology Only Market
Chapter six: Competitive Analysis
Competitive Landscape
Chapter seven: Company Profiles
- ALZA Corporation
- Andrx Pharmaceuticals
- Biovail Corporation
- Cardinal Health
- Elan Corporation, plc
- Emisphere Technologies, Inc.
- KV Pharmaceutical
- Labopharm, Inc.
- Penwest Pharmaceutical Company
- Purdue/MundiPharma/Napp Group
- SkyePharma PLC
Chapter eight: Companies in Brief
- Alkermes, Inc.
- Astellas
- BioProgress Technologies International, Inc.
- CIMA Labs, Inc. Division of Cephalon
- DepoMed, Inc.
- Endorex, Inc.
- Eurand, Inc.
- Kos Pharmaceuticals, Inc.
- Lipocine, Inc.
Appendix: Company Directory
List of Exhibits
Chapter one: Executive Summary
Chapter two: Introduction and Overview
- Table 2-1: Selected Types of Oral Solid Preparations
- Table 2-2: Sequence of Drug Action
Chapter three: Key Trends and Demographics
- Table 3-1: World Population by Age Group 2002-2010
- Figure 3-1: World Population by Age Group 2002-2010
- Table 3-2: Recent Consolidations in the Drug Delivery Market
Chapter four: New Developments
Chapter five: Market Size and Growth
- Table 5-1: The Worldwide Market for Oral Drug Delivery Technology and Pharmaceuticals Revenues and Growth Rate 2002-2010
- Figure 5-1: Trending in the Worldwide Market for Oral Drug Delivery Technology and Pharmaceuticals 2002-2010
- Table 5-2: The Worldwide Market for Pharmaceuticals Utilizing Oral Drug Delivery Technologies by Type 2002-2010
- Figure 5-2: Trending in the Worldwide Market for Pharmaceuticals Utilizing Oral Drug Delivery Technologies by Type 2002-2010
- Table 5-3: The Worldwide Market for Pharmaceuticals Utilizing Oral Drug Market Share by Type 2002-2010
- Table 5-4: The Worldwide Market for Oral Drug Delivery Systems by Pharmaceutical vs Drug Delivery Components 2002-2010
- Table 5-5: The Worldwide Market for Oral Drug Delivery Systems Distribution of Revenue by Pharmaceutical vs Drug Delivery Component 2002-2010
- Figure 5-3: The Worldwide Market for Oral Drug Delivery Systems Share of Revenue by Pharmaceutical and Drug Delivery Component 2006, 2010
Chapter six: Competitive Analysis
- Table 6-1: Leading Suppliers of Oral Drug Delivery Technology (Company, Proprietary Technology, Approved Products)
Drug Delivery Markets, 2nd Edition, Vol II: Implantable / Injectable Delivery Systems
Chapter one: Executive Summary
- Market Drivers
- Market Size and Growth
- Total Injectable/Implantable Drug Delivery Market
- The Injectable/Implantable Drug Delivery Only Market
- Competitor and Market Analysis
Chapter two: Introduction
- Scope and Methodology
- Reasons for Injectable/Implantable Drug Delivery Systems
- History of Injectable/Implantable Drug Delivery
- Phases of Drug Action
- Needle-Free Drug Delivery
- Major Applications
- Safety Concerns
- Products
- Implantable Drug Delivery
- Mechanisms
- Applications
- Products
- Sustained-Release Drug Delivery
- Targeted Injection Drug Delivery
Chapter three: Trends and Developments
- Drivers of the Injectable/Implantable Drug Delivery Market
- Pen injectors
- Proprietary Product Development
- Delivery Systems Placement Trends
- Therapeutic Trends
- Incorporation of Technology
- Nanotechnology
- Drug Delivery Development
- Microsphere Technology
- Targeted Technology
- MicroChip Technology
- NanoParticles
- Protein-Coated Microcrystal Technology
- Needle-Free Delivery Development
- Selected Products in Development
Chapter four: Market Size and Growth
- The Total Injectable/Implantable Drug Delivery Market
- Injectable/Implantable Delivery Technology Only Market
chapter five: Competitive and Market Analysis
- Competitive Landscape
- Market Analysis
Chapter six: Company Profiles
- Alkermes, Inc.
- ALZA Corp.
- Antares Pharma, Inc.
- Bioject Medical Technologies, Inc.
- CyDex, Inc.
- MGI Pharma, Inc
- Nektar Therapeutics
- PowderMed Pharmaceuticals Plc
- SkyePharma Plc
- Zogenix Corporation
Chapter seven: Companies in Brief
- AP Pharma
- Baxter BioPharma Solutions
- ImaRx Therapeutics Inc.
- PR Pharmaceuticals, Inc.
- pSivida
- QLT USA, Inc
Appendix: Company Directory
TABLE OF EXHIBITS
Chapter one: Executive Summary
- Figure 1-1: The Worldwide Market for Injectable/Implantable
- Drug Delivery Technology and Pharmaceuticals 2002-2010
Chapter two: Introduction
- Table 2-1: Sequence of Drug Action
Chapter three: Trends and Developments
- Table 3-1: Select Products in Early Stage Development by Drug
- Delivery Companies
Chapter four: Market Size and Growth
- Table 4-1: Worldwide Market for Injectable/Implantable Drug Delivery
Technology and Pharmaceuticals 2002-2010
- Figure 4-1: Worldwide Market for Injectable/Implantable Drug Delivery
Technology and Pharmaceuticals 2002-2010
- Table 4-2: Worldwide Market for Pharmaceuticals Utilizing Injectable/
Implantable Drug Delivery by Type 2002-2010
- Figure 4-2: Worldwide Market for Pharmaceuticals Utilizing Injectable/
Implantable Drug Delivery by Type 2002-2010
- Table 4-3: Worldwide Market for Pharmaceuticals Utilizing Injectable/
Implantable Drug Delivery Market Share by Type 2002-2010
- Figure 4-3: Worldwide Market for Pharmaceuticals Utilizing Injectable/
Implantable Drug Delivery Market Share by Type 2006
- Figure 4-4: Worldwide Market for Pharmaceuticals Utilizing Injectable/
Implantable Drug Delivery Market Share by Type 2010
- Table 4-4: Worldwide Market for Injectable/Implantable Drug Delivery
Systems by Pharmaceutical and Drug Delivery Component 2002-2010
- Table 4-5: Injectable/Implantable Drug Delivery Systems: Worldwide Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2002-2010
- Figure 4-5: Injectable/Implantable Drug Delivery Systems Worldwide Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2006
- Figure 4-6: Injectable/Implantable Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2010
chapter five: Competitive and Market Analysis
- Table 5-1: Leading Suppliers of Injectable/Implantable Drug Delivery Technology
- Figure 5-1: Cost per Million Injections by Injector Type
Drug Delivery Markets, Vol III: Pulmonary Delivery Systems
Chapter one: Executive Summary
- Market Drivers
- Market Size and Growth
- The Total Pulmonary Drug Delivery Market
- The Total Pulmonary Drug Delivery Only Market
- Competitor and Market Analysis
Chapter two: Introduction and Overview
- Scope and Methodology
- Reasons for pulmonary Drug Delivery Systems
- History and Mechanics of Pulmonary Drug Delivery
- Phases of Drug Action
- Pharmacokinetics of Inhalation
- Inhalation Delivery Technologies
- Metered Dose Inhalers
- Dry Powder Formulations
- Nebulizer Delivery Formulations
- Liquid Formulations
- Nanospheres
- Intranasal Delivery Technologies
Chapter three: Trends and Demographics
- Asthma
- Opportunities for Drug Delivery System Success
- Exubera Breakthrough
- Nano and Microparticulate Systems
- Trends in Liquid Aerosols
- CFC Phase Out
- Expansion of Biotechnology
- Macromolecule Delivery
Chapter four: New Developments
- Prodrug Drug Delivery
- Electrohydrodynamic Aerosol Delivery
- Oxygen Delivery
- Crystallization Technology
Chapter five: Market Size and Growth
- The Total Pulmonary Drug Delivery Market
- Pulmonary Delivery Technology Only Market
Chapter six: Competitive and Market Analysis
- Competitor Analysis
- Market Analysis
Chapter seven: Company Profiles
- 3M Pharmaceuticals
- Alkermes, Inc.
- Aradigm Corporation
- Elan Corporation, Plc
- Innovata BioMed Plc
- MicroDose Technology, Inc
- Nastech Pharmaceutical Company Inc.
- Nektar Therapeutics
- Oriel Therapeutics
- Pipex Pharmaceuticals
- Resiprics, Inc.
- SkyePharma Plc
- Vectura Ltd.
- Ventaira Pharmaceuticals, Inc.
Chapter eight: Companies in Brief
- Bespak
- Direct Haler A/S
- IntraNasal Therapeutics
Appendix: Company Directory
TAble of exhibits
Chapter one: Executive Summary
- Table 1-1: The Worldwide Market for Pulmonary Drug Delivery Technology
and Pharmaceuticals 2002-2010
- Figure 1-1: The Worldwide Market for Pulmonary Drug Delivery Technology and
Pharmaceuticals 2002-2010
- Table 1-2: The Worldwide Market for Pulmonary Drug Delivery Systems by
Pharmaceutical and Drug Delivery Component 2002-2010
- Figure 1-2: The Worldwide Market for Pulmonary Drug Delivery Systems Distribution
of Revenue by Pharmaceutical and Drug Delivery Component 2002-2010
Chapter two: Introduction and Overview
- Table 2-1: Sequence of Drug Action
Chapter three: Trends and Demographics
- Table 3-1: Worldwide Prevalence of Asthma 2006
- Figure 3-1: Worldwide Prevalence of Asthma 2006
- Table 3-2: World Population by Age Group 2002-2010
- Figure 3-2: World Population by Age Group 2002-2010
Chapter fivE: Market Size and Growth
- Table 5-1: The Worldwide Market for Pulmonary Drug Delivery Technology and
Pharmaceuticals 2002-2010
- Figure 5-1: The Worldwide Market for Pulmonary Drug Delivery Technology and
Pharmaceuticals 2002-2010
- Table 5-2: The Worldwide Market for Pharmaceuticals Utilizing Pulmonary Drug
Delivery Systems by Type 2002-2010
- Figure 5-2: The Worldwide Market for Pharmaceuticals Utilizing Pulmonary Drug
Delivery Systems Revenues by Type 2002-2010
- Table 5-3: The Worldwide Market for Pharmaceuticals Utilizing Pulmonary Drug
Delivery Technologies Market Share by Type 2002-2010
- Figure 5-3: The Worldwide Market for Pharmaceuticals Utilizing Pulmonary Drug
Delivery Technologies by Type 2006
- Figure 5-4: The Worldwide Market for Pharmaceuticals Utilizing Pulmonary Drug
Delivery Technologies by Type 2010
- Table 5-4: The Worldwide Market for Pulmonary Drug Delivery Systems by
Pharmaceutical and Drug Delivery Component 2002-2010
- Table 5-5
of Revenue by Pharmaceutical and Drug Delivery Component 2002-2010
- Figure 5-5
of Revenue by Pharmaceutical and Drug Delivery Component 2002-2010
- Figure 5-6: The Worldwide Market for Pulmonary Drug Delivery Systems
Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2006
- Figure 5-7: The Worldwide Market for Pulmonary Drug Delivery Systems
Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2010
Chapter six: Competitive and Market Analysis
- Table 6-1: Selected Leading and Emerging Suppliers of Pulmonary Drug
- Delivery Technology
Drug Delivery Markets, Vol. IV: Transdermal
Chapter One: Executive Summary
- Market Drivers
- Market Size and Growth
- Total Transdermal/Transmucosal Drug Delivery Market
- Transdermal/Transmucosal Drug Delivery Only Market
- Competitive and Market Analysis
Chapter Two: Introduction and Overview
- Scope and Methodology
- Reasons for Transdermal/Transmucosal Drug Delivery Systems
- History of Transdermal and Transmucosal Drug Delivery
- Phases of Drug Action
- Topical Drug Delivery
- Types of Topical Preparations
- Market Participants
- Transdermal Patch Drug Delivery
- Membrane-Controlled System
- Adhesive Dispersion-Type System
- Matrix Diffusion-Controlled System
- Microreservoir Dissolution-Controlled System
- New Transdermal Drug Applications and Approvals
- Electrotransport Drug Delivery
- Iontophoresis
- Transmucosal Drug Delivery
- Oral Transmucosal Fentanyl Citrate (OTFC)
- Transmucosal Etomidate
- Ondansetron ODT
- Buccal Drug Delivery
- Vaginal Drug Delivery
Chapter three: Trends and Developments
- Innovations in Transdermal Drug Delivery
- Adhesive Technology and Issues
- Adhesive Market Issues
- Biotechnological Issues
- Iontophoresis and Sonophoresis
- Developments in Insulin Delivery
- New Developments in Hormone Drug Delivery
- New Mucosal/Buccal Delivery Systems
- Other New Drug Delivery Systems
- Macroflux Technology
- Controlled Thermal Energy Technology
- New Ultrasound Technology
- Combination Delivery Technology
- Transdermal Products in Development
Chapter four: Market Size and Growth
- The Total Transdermal/Transmucosal Drug Delivery Market
- Transdermal/Transmucosal Delivery Technology Only Market
chapter five: Competitive Analysis
- Competitive Landscape
- Market Analysis
CHAPTER SIX: Company Profiles
- 3M Pharmaceuticals
- Acrux Limited
- Altea Therapeutics, Inc
- ALZA Corporation
- Antares Pharma, Inc.
- Aveva Drug Delivery Systems
- Cardinal Health
- Cephalon Inc
- Generex Biotechnology Corporation
- Inovio Biomedical Corporation
- Labtec GmbH
- Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)................
- MacroChem Corporation
- NexMed, Inc.
- Noven Pharmaceuticals, Inc.
- SkyePharma PLC
Appendix
Company Directory
Table of exhibits
chapter twO: Introduction and Overview
- Table 2-1: Sequence of Drug Action
Chapter three: Trends and Developments
- Table 3-1: Selected Transdermal Products in Development
Chapter four: Market Size and Growth
- Table 4-1: The Worldwide Market for Transdermal/Transmucosal Drug Delivery
Technology and Pharmaceuticals 2002-2010
- Figure 4-1.. : The Worldwide Market for Transdermal/Transmucosal Drug Delivery
Technology and Pharmaceuticals 2002-2010
- Table 4-2: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/
Transmucosal Drug Delivery Systems by Type 2002-2010
- Figure 4-2: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/
Transmucosal Drug Delivery Systems Revenues by Type 2002-2010
- Table 4-3: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/
Transmucosal Drug Delivery Technologies Market Share by Type 2002-2010.......
- Figure 4-3: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/
Transmucosal Drug Delivery Technologies by Type 2006
- Figure 4-4: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/
Transmucosal Drug Delivery Technologies by Type 2010
- Table 4-4: The Worldwide Market for Transdermal/Transmucosal Drug Delivery
Systems by Pharmaceutical and Drug Delivery Component 2002-2010
- Table 4-5: The Worldwide Market for Transdermal/Transmucosal Drug Delivery
Systems Distribution of Revenue by Pharmaceutical and Drug Delivery
Component 2002-2010
- Figure 4-5.. : The Worldwide Market for Transdermal/Transmucosal Drug Delivery
Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2002-2010
- Figure 4-6: The Worldwide Market for Transdermal/Transmucosal Drug Delivery
Systems Distribution of Revenue by Pharmaceutical and Drug Delivery
Component 2006
- Figure 4-7: The Worldwide Market for Transdermal/Transmucosal Drug Delivery
Systems Distribution of Revenue by Pharmaceutical and Drug Delivery
Component 2010
chapter five: Competitive Analysis
- Table 5-1: Leading Suppliers of Transdermal/Transmucosal Drug Delivery Technology
